The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians after the US Food and Drug Administration announced a recall of about 90,000 bottles of children’s ibuprofen oral suspension because consumers reported foreign material — described as a “gel-like mass” and “black particles.”
Strides Pharma Inc. initiated the recall; the product was manufactured in India for Taro Pharmaceuticals USA. Affected lot numbers are 7261973A and 7261974A, with an expiry date of January 31, 2027. Although the recalled batches were distributed in the United States, NAFDAC is taking precautions to prevent the product from entering Nigeria through authorized or unauthorized channels. The agency has instructed its zonal directors and state coordinators to step up surveillance and remove any identified items.
NAFDAC warns that contaminated medicinal products can compromise quality, safety, and effectiveness, and that administering contaminated oral suspensions to children may cause adverse reactions or pose choking or gastrointestinal risks. It urged importers, distributors, retailers, healthcare facilities, and professionals to source medical products only from authorized, licensed suppliers, inspect inventories immediately, and quarantine any affected batches.
